ScripThe multibillion-dollar monoclonal antibody sector may be based on immunoglobulin G (IgG) antibodies, but there are good reasons to believe immunotherapies based on another antibody isotype, IgE, coul
In VivoIN VITRO DIAGNOSTICS Alliances Clearbridge BioMedics Pte. Ltd. Danaher Corp. Leica Biosystems Ltd. Leica Biosystems Ltd. and Clearbridge BioMedics Pte. Ltd. will co-promote each other’s automa
ScripThe progression of investigational products through a series of increasingly more sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for c
ScripThe ovarian cancer market will experience significant growth over the next five years as novel therapies complete pivotal trials and make their way through regulatory agencies; the value of the US mar